Mackenzie Financial’s Dr. Reddy's Laboratories RDY Stock Holding History

Mackenzie Financial’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-185,500	Closed	-$1.51M	–	1157
2019 Q4	$1.51M	Buy	+185,500	New	+$1.46M	﹤0.01%	668
2019 Q2	–	Sell	-67,500	Closed	-$547K	–	1226
2019 Q1	$547K	Buy	+67,500	New	+$513K	﹤0.01%	1011
2018 Q4	–	Sell	-100,300	Closed	-$694K	–	1222
2018 Q3	$694K	Buy	100,300 +37,300	+59%	+$249K	﹤0.01%	821
2018 Q2	$406K	Buy	+63,000	New	+$397K	﹤0.01%	830
2015 Q4	–	Sell	-144,050	Closed	-$1.84M	–	828
2015 Q3	$1.84M	Buy	144,050 +71,090	+97%	+$883K	0.01%	424
2015 Q2	$807K	Buy	72,960 +30,460	+72%	+$336K	﹤0.01%	595
2015 Q1	$485K	Buy	+42,500	New	+$451K	﹤0.01%	670

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Mackenzie Financial's RDY Position: Q1 2020 in Review

Mackenzie Financial sold out of Dr. Reddy's Laboratories (RDY) in Q1 2020, closing a stake of 185,500 shares — an estimated $1.51M sold.

Mackenzie Financial first reported a position in RDY in Q1 2015 and held it in 7 quarters. The position peaked at $1.84M in Q3 2015. 148 funds tracked by Wall St. Rank hold RDY as of Q1 2020.

Mackenzie Financial reported no remaining Dr. Reddy's Laboratories position as of Q1 2020 after selling out during the quarter.
Mackenzie Financial sold 185,500 Dr. Reddy's Laboratories shares in Q1 2020, an estimated $1.51M.
Mackenzie Financial first reported a position in Dr. Reddy's Laboratories in Q1 2015 and held it in 7 quarters.
Mackenzie Financial's Dr. Reddy's Laboratories position peaked at $1.84M in Q3 2015.
148 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2020.

Based on Mackenzie Financial's 13F filing for Q1 2020, filed 14 May 2020.